<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK542808" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK542808/" /><meta name="ncbi_pagename" content="STAC3 Disorder - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>STAC3 Disorder - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="STAC3 Disorder" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/06/20" /><meta name="citation_author" content="Bryn D Webb" /><meta name="citation_author" content="Irini Manoli" /><meta name="citation_author" content="Ethylin Wang Jabs" /><meta name="citation_pmid" content="31219695" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK542808/" /><meta name="citation_keywords" content="Native American Myopathy" /><meta name="citation_keywords" content="Native American Myopathy" /><meta name="citation_keywords" content="SH3 and cysteine-rich domain-containing protein 3" /><meta name="citation_keywords" content="STAC3" /><meta name="citation_keywords" content="STAC3 Disorder" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="STAC3 Disorder" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Bryn D Webb" /><meta name="DC.Contributor" content="Irini Manoli" /><meta name="DC.Contributor" content="Ethylin Wang Jabs" /><meta name="DC.Date" content="2019/06/20" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK542808/" /><meta name="description" content="STAC3 disorder is characterized by congenital myopathy, musculoskeletal involvement of the trunk and extremities, feeding difficulties, and delayed motor milestones. Most affected individuals have weakness with myopathic facies, scoliosis, kyphosis or kyphoscoliosis, and contractures. Other common findings are ptosis, abnormalities of the palate (including cleft palate), and short stature. Risk for malignant hyperthermia susceptibility and restrictive lung disease are increased. Intellect is typically normal. Originally described in individuals from the Lumbee Native American tribe (an admixture of Cheraw Indian, English, and African American ancestry) in the state of North Carolina and reported as Native American myopathy, STAC3 disorder has now been identified in numerous other populations worldwide." /><meta name="og:title" content="STAC3 Disorder" /><meta name="og:type" content="book" /><meta name="og:description" content="STAC3 disorder is characterized by congenital myopathy, musculoskeletal involvement of the trunk and extremities, feeding difficulties, and delayed motor milestones. Most affected individuals have weakness with myopathic facies, scoliosis, kyphosis or kyphoscoliosis, and contractures. Other common findings are ptosis, abnormalities of the palate (including cleft palate), and short stature. Risk for malignant hyperthermia susceptibility and restrictive lung disease are increased. Intellect is typically normal. Originally described in individuals from the Lumbee Native American tribe (an admixture of Cheraw Indian, English, and African American ancestry) in the state of North Carolina and reported as Native American myopathy, STAC3 disorder has now been identified in numerous other populations worldwide." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK542808/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/stac3-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK542808/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BD8C0E0417101000000000029000C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK542808_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK542808_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hsn1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/stxbp1-ee/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK542808_"><span class="title" itemprop="name"><i>STAC3</i> Disorder</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Native American Myopathy</div><p class="contrib-group"><span itemprop="author">Bryn D Webb</span>, MD, <span itemprop="author">Irini Manoli</span>, MD, PhD, and <span itemprop="author">Ethylin Wang Jabs</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK542808_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK542808_ai__"><div class="contrib half_rhythm"><span itemprop="author">Bryn D Webb</span>, MD<div class="affiliation small">Icahn School of Medicine at Mount Sinai<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mssm@bbew.nyrb" class="oemail">ude.mssm@bbew.nyrb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Irini Manoli</span>, MD, PhD<div class="affiliation small">National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@iilonam" class="oemail">vog.hin.liam@iilonam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ethylin Wang Jabs</span>, MD<div class="affiliation small">Icahn School of Medicine at Mount Sinai<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mssm@sbaj.nilyhte" class="oemail">ude.mssm@sbaj.nilyhte</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 20, 2019</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="stac3-dis.Summary" itemprop="description"><h2 id="_stac3-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>STAC3</i> disorder is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathy, musculoskeletal involvement of the trunk and extremities, feeding difficulties, and delayed motor milestones. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have weakness with myopathic facies, scoliosis, kyphosis or kyphoscoliosis, and contractures. Other common findings are ptosis, abnormalities of the palate (including cleft palate), and short stature. Risk for malignant hyperthermia susceptibility and restrictive lung disease are increased. Intellect is typically normal. Originally described in individuals from the Lumbee Native American tribe (an admixture of Cheraw Indian, English, and African American ancestry) in the state of North Carolina and reported as Native American myopathy, <i>STAC3</i> disorder has now been identified in numerous other populations worldwide.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>STAC3</i> disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>STAC3</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> At present, no treatment halts or reverses the manifestations of <i>STAC3</i> disorder. Treatment of musculoskeletal involvement is symptomatic and ideally provided by a multidisciplinary neuromuscular team to address the following:</p><ul><li class="half_rhythm"><div>Occupational and physical therapy needs regarding range of motion and mobility</div></li><li class="half_rhythm"><div>Use of adaptive devices for mobility and activities of daily living</div></li><li class="half_rhythm"><div>Feeding difficulties</div></li><li class="half_rhythm"><div>Speech delays</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Respiratory insufficiency</div></li></ul><p>Due to the medical comorbidities in <i>STAC3</i> disorder, decisions regarding type and timing of cleft palate surgery should be determined by a multidisciplinary craniofacial team. Depending on the structure of the managing craniofacial team, interventions for ptosis may be undertaken by an ophthalmologist as part of team care, or as an insertion intervention.</p><p><i>Surveillance:</i> Routine monitoring of growth, musculoskeletal complications (e.g., scoliosis and/or joint contractures), speech development, swallowing function, respiratory function, and educational needs.</p><p><i>Agents/circumstances to avoid:</i> Anesthetic agents with a high risk of triggering malignant hyperthermia.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>STAC3</i> disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Unless an individual with <i>STAC3</i> disorder has children with an affected individual or a carrier, his/her offspring will be obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>STAC3.</i> Once the <i>STAC3</i> pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> of at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="stac3-dis.Diagnosis"><h2 id="_stac3-dis_Diagnosis_">Diagnosis</h2><p>Formal diagnostic criteria for <i>STAC3</i> disorder have not been established.</p><div id="stac3-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>STAC3</i> disorder (also known as Native American myopathy) <b>should be suspected</b> in individuals with the following clinical and laboratory findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div><b>Congenital myopathy</b></div><ul><li class="half_rhythm"><div>Congenital weakness</div></li><li class="half_rhythm"><div>Myopathic facies, characterized by ptosis, inability to raise corners of mouth, and (in some individuals) hollowed-out cheeks from loss of facial musculature, which may cause an open-mouthed expressionless appearance with downturned corners of the mouth. Over time, the face often becomes long and narrow.</div></li></ul></li><li class="half_rhythm"><div><b>Musculoskeletal anomalies</b></div><ul><li class="half_rhythm"><div>Congenital contractures ranging from talipes equinovarus (bilateral or unilateral) with or without other joint contractures to arthrogryposis (i.e., multiple contractures of the joints in more than one area of the body present at birth) [<a class="bk_pop" href="#stac3-dis.REF.hall.2010">Hall 2010</a>]</div></li><li class="half_rhythm"><div>Scoliosis, kyphosis, or kyphoscoliosis</div></li></ul></li><li class="half_rhythm"><div><b>Palatal anomalies</b> including cleft palate</div></li><li class="half_rhythm"><div><b>Micrognathia</b></div></li><li class="half_rhythm"><div><b>Characteristic facial features.</b> Myopathic facies, micrognathia, and palatal anomalies can be seen in a number of neuromuscular disorders of varying etiologies; the characteristics that best distinguish <i>STAC3</i> disorder from other conditions include low-set and/or posteriorly rotated ears, short and/or downslanting palpebral fissures, and telecanthus [<a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al 2008a</a>] (see <a href="https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.a.32370" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Figure 2: A-I</a>).</div></li><li class="half_rhythm"><div><b>Short stature</b></div></li><li class="half_rhythm"><div><b>Susceptibility to malignant hyperthermia</b></div></li></ul><p><b>Laboratory findings.</b> Creatine kinase baseline levels are most often normal [<a class="bk_pop" href="#stac3-dis.REF.stewart.1988.371">Stewart et al 1988</a>].</p></div><div id="stac3-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>STAC3</i> disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinical findings consistent with <a href="#stac3-dis.Suggestive_Findings">Suggestive Findings</a> and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>STAC3</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figstac3disTmoleculargenetictestingus" rid-ob="figobstac3disTmoleculargenetictestingus">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>STAC3</i> disorder is broad, individuals with the distinctive findings described in <a href="#stac3-dis.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#stac3-dis.Option_1">Option 1</a>), whereas those in whom the diagnosis of <i>STAC3</i> disorder has not been considered are more likely to be diagnosed using genomic testing (see <a href="#stac3-dis.Option_2">Option 2</a>).</p><div id="stac3-dis.Option_1"><h4>Option 1</h4><p>When the phenotypic findings suggest the diagnosis of <i>STAC3</i> disorder, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>STAC3</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications. Note: To date no large <i>STAC3</i> deletions or duplications have been identified in individuals reported with molecularly confirmed <i>STAC3</i> disorder.</div><div class="half_rhythm">Note: Targeted analysis for the <i>STAC3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.stac3_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figstac3disTstac3pathogenicvariantsdi" rid-ob="figobstac3disTstac3pathogenicvariantsdi">c.851G&#x0003e;C</a> can be performed first in individuals of Lumbee Native American ancestry [<a class="bk_pop" href="#stac3-dis.REF.horstick.2013.1952">Horstick et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathy</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>STAC3</i> and other genes of interest (see <a href="#stac3-dis.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of <i>STAC3</i> disorder, some panels for congenital myopathy may not include this gene. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="stac3-dis.Option_2"><h4>Option 2</h4><p>When the diagnosis of STAC3 disorder is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. Note: To date no large <i>STAC3</i> deletions or duplications have been identified in individuals reported with molecularly confirmed <i>STAC3</i> disorder.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="stac3-dis.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>STAC3</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_stac3-dis.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_stac3-dis.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_stac3-dis.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_stac3-dis.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>STAC3</i></td><td headers="hd_h_stac3-dis.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_stac3-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All pathogenic variants reported to date&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_stac3-dis.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_stac3-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To date no deletions/duplications have been identified.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="stac3-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK542808/#stac3-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="stac3-dis.TF.1.2"><p class="no_margin">See <a href="#stac3-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="stac3-dis.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="stac3-dis.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#stac3-dis.REF.horstick.2013.1952">Horstick et al [2013]</a>, <a class="bk_pop" href="#stac3-dis.REF.grzybowski.2017.451">Grzybowski et al [2017]</a>, <a class="bk_pop" href="#stac3-dis.REF.telegrafi.2017.2763">Telegrafi et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="stac3-dis.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="stac3-dis.Clinical_Characteristics"><h2 id="_stac3-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="stac3-dis.Clinical_Description"><h3>Clinical Description</h3><p><i>STAC3</i> disorder is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathy and musculoskeletal involvement of the trunk and extremities. Most children have weakness with myopathic facies, progressive kyphoscoliosis, and contractures. Other common findings are palatal anomalies (including cleft palate) and short stature. Risks for malignant hyperthermia susceptibility and restrictive lung disease are increased. Intellect is typically normal.</p><p>Prior to knowledge of its genetic cause, <i>STAC3</i> disorder was initially reported as Native American myopathy in an infant from the Lumbee tribe whose findings at birth included arthrogryposis with talipes equinovarus, cleft palate, and micrognathia; at age three months she developed malignant hyperthermia during halothane anesthesia for gastrostomy tube placement due to poor feeding [<a class="bk_pop" href="#stac3-dis.REF.bailey.1987.1043">Bailey &#x00026; Bloch 1987</a>]. Subsequently 20 additional individuals of Lumbee descent with a clinical diagnosis of Native American myopathy were reported, six by <a class="bk_pop" href="#stac3-dis.REF.stewart.1988.371">Stewart et al [1988]</a> and 14 by <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al [2008a]</a>. Additional variable findings included ptosis, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> joint contractures, and scoliosis.</p><p>Following the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>STAC3</i> in five individuals with Native American myopathy from five families of Lumbee descent by <a class="bk_pop" href="#stac3-dis.REF.horstick.2013.1952">Horstick et al [2013]</a>, <i>STAC3</i> disorder has been confirmed molecularly in another 23 individuals from 15 families of various ancestry: African (5 families), Middle Eastern (4), Puerto Rican (1), Turkish (1), Afro-Caribbean (1), Comoro Islands (1), South American (1), and mixed African and Afro-Caribbean (1) [<a class="bk_pop" href="#stac3-dis.REF.grzybowski.2017.451">Grzybowski et al 2017</a>, <a class="bk_pop" href="#stac3-dis.REF.telegrafi.2017.2763">Telegrafi et al 2017</a>, <a class="bk_pop" href="#stac3-dis.REF.zaharieva.2018.1980">Zaharieva et al 2018</a>].</p><p>The findings of all individuals reported to date with molecularly confirmed <i>STAC3</i> disorder and clinically diagnosed Native American myopathy are summarized in <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.clinical_findings_in_individ/?report=objectonly" target="object" rid-figpopup="figstac3disTclinicalfindingsinindivid" rid-ob="figobstac3disTclinicalfindingsinindivid">Table 2</a> and discussed in more detail in the text that follows the table.</p><div id="stac3-dis.T.clinical_findings_in_individ" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Clinical Findings in Individuals with <i>STAC3</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.T.clinical_findings_in_individ/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.T.clinical_findings_in_individ_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Finding</th><th id="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lumbee&#x000a0;<sup>1</sup><br />(n=21)</th><th id="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Non-Lumbee&#x000a0;<sup>2</sup> (n=23)</th><th id="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Total (n=44)</th></tr></thead><tbody><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Congenital myopathy</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypotonia</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21/21</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20/20 (3 not recorded)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">41/41</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Myopathic facies</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21/21</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23/23</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">44/44</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Ptosis</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/16 (5 not recorded)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19/23</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">33/39</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Poor feeding</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11/17 (4 not recorded)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/23</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">29/40</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Musculo-<br />skeletal</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital contractures</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/20 (1 not recorded)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/23</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">35/43</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Scoliosis, kyphosis, or kyphoscoliosis</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15/16 (5 not recorded)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">16/23</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">31/39</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Short stature</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/6 (not recorded&#x000a0;<sup>3</sup>)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13/23</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19/29</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Palate anomalies (cleft palate, high-arched palate, or bifid uvula)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21/21 (16 w/cleft palate)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15/23 (9 w/cleft palate)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">36/44 total (25/44 w/cleft palate)</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Malignant hyperthermia</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/21</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12/23</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19/44</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Respiratory impairment</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/6 (not recorded&#x000a0;<sup>4</sup>)</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11/23</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">16/29</td></tr><tr><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cryptorchidism</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/8 males</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/13 males</td><td headers="hd_h_stac3-dis.T.clinical_findings_in_individ_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13/21 males</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="stac3-dis.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#stac3-dis.REF.bailey.1987.1043">Bailey &#x00026; Bloch [1987]</a> (n=1), <a class="bk_pop" href="#stac3-dis.REF.stewart.1988.371">Stewart et al [1988]</a> (n=6), <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al [2008a]</a> (n=14). The five individuals of Lumbee descent with molecularly confirmed <i>STAC3</i> disorder reported in <a class="bk_pop" href="#stac3-dis.REF.horstick.2013.1952">Horstick et al [2013]</a> were previously described in <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al [2008a]</a>.</p></div></dd><dt>2. </dt><dd><div id="stac3-dis.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#stac3-dis.REF.grzybowski.2017.451">Grzybowski et al [2017]</a> (n=1), <a class="bk_pop" href="#stac3-dis.REF.telegrafi.2017.2763">Telegrafi et al [2017]</a> (n=4), <a class="bk_pop" href="#stac3-dis.REF.zaharieva.2018.1980">Zaharieva et al [2018]</a> (n=18). All of these cases were molecularly confirmed.</p></div></dd><dt>3. </dt><dd><div id="stac3-dis.TF.2.3"><p class="no_margin">6/6 patients in Stewart et at [1988] had short stature; 2/2 adults in <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al [2008a]</a> had short stature (not included in tally); information was incomplete on all other individuals in <a class="bk_pop" href="#stac3-dis.REF.bailey.1987.1043">Bailey &#x00026; Bloch [1987]</a> and <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al [2008a]</a>.</p></div></dd><dt>4. </dt><dd><div id="stac3-dis.TF.2.4"><p class="no_margin">At least two individuals in <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al [2008a]</a> had respiratory findings (not included in tally); information was incomplete on additional individuals.</p></div></dd></dl></div></div></div><p><b>Congenital myopathy.</b> The <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathy is slowly progressive with myopathic facies. Deep tendon reflexes in the upper and lower extremities are often decreased or absent. Strength is often decreased in facial, axial, and proximal limb muscles, and may be decreased in distal limb muscles. Examination of older <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may reveal muscle wasting.</p><p>Motor delays are most often present by infancy or very early childhood. The maximum motor ability in 15 individuals old enough for evaluation was walking (11), short walk (2), running (1), and sitting independently (1) [<a class="bk_pop" href="#stac3-dis.REF.zaharieva.2018.1980">Zaharieva et al 2018</a>]. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may be wheelchair bound by adolescence.</p><p><b>Feeding problems.</b> Poor feeding may be due to a combination of structural differences (e.g., cleft palate or high-arched palate, micrognathia) and functional differences (e.g., weak suck, impaired coordination of feeding, abnormal tongue movements, respiratory insufficiency). Descending aspiration may also contribute to feeding and respiratory difficulties. Children with micrognathia and cleft palate may be at increased risk for respiratory issues during feeding (see <a href="#stac3-dis.Management">Management</a>).</p><p>Ptosis refers to downward placement (i.e., drooping) of the upper eyelids. In children, ptosis that obstructs the pupil may result in vision impairment or amblyopia. Ptosis may also cause loss of peripheral vision and blurred vision. To maximize vision individuals with ptosis may assume a posture with head tilted backwards and chin pointed upwards.</p><p><b>Musculoskeletal.</b> Congenital contractures can involve the fingers (camptodactyly), hands, wrists, elbows, hips, knees, or feet/ankles (talipes equinovarus). The severity and functional disability range from mild to severe and depend on the joint involved.</p><p>Joint laxity has been seen in individuals with or without contractures.</p><p>Spinal involvement, including scoliosis, kyphosis, or kyphoscoliosis, is often present by early childhood and is often progressive.</p><p><b>Short stature.</b> Adult height is commonly below the third percentile. Birth length is most often normal.</p><p><b>Speech impairments.</b> Speech development is typically abnormal and dysarthria is common. Factors that can contribute to speech issues in children with <i>STAC3</i> disorder include the following (see also <a href="#stac3-dis.Management">Management</a>):</p><ul><li class="half_rhythm"><div>Abnormal palatal formation, including cleft palate</div></li><li class="half_rhythm"><div>Abnormal tongue movement</div></li><li class="half_rhythm"><div>Compensatory misarticulation</div></li><li class="half_rhythm"><div>Velopharyngeal insufficiency</div></li><li class="half_rhythm"><div>Neurologic factors</div></li><li class="half_rhythm"><div>Atypical resonance</div></li><li class="half_rhythm"><div>Respiratory insufficiency</div></li><li class="half_rhythm"><div>Apraxia</div></li></ul><p><b>Malignant hyperthermia (MH).</b> All individuals with a reported history of MH survived. Of the cases in which details were provided, most individuals were treated by discontinuing the anesthetic and surgery, and administering dantrolene [<a class="bk_pop" href="#stac3-dis.REF.bailey.1987.1043">Bailey &#x00026; Bloch 1987</a>, <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al 2008a</a>].</p><p>Although MH has been reported in a significant number of individuals, the true frequency of MH susceptibility is likely higher as not all reported individuals had prior surgery or had been exposed to an MH-provoking anesthetic.</p><p><b>Respiratory impairment.</b> Respiratory insufficiency may present in early childhood, late childhood, or adulthood [<a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al 2008a</a>, <a class="bk_pop" href="#stac3-dis.REF.telegrafi.2017.2763">Telegrafi et al 2017</a>, <a class="bk_pop" href="#stac3-dis.REF.zaharieva.2018.1980">Zaharieva et al 2018</a>].</p><p><b>Other.</b> The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal intelligence; mild intellectual disability is rare [<a class="bk_pop" href="#stac3-dis.REF.stewart.1988.371">Stewart et al 1988</a>, <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al 2008a</a>].</p><p>Conductive hearing loss is common.</p><p>Facial hemangiomas may also be present.</p><p><b>Life expectancy.</b> Thirty-six percent of individuals <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with <i>STAC3</i> disorder died by age 18 years [<a class="bk_pop" href="#stac3-dis.REF.horstick.2013.1952">Horstick et al 2013</a>]. In a study of 14 affected individuals, three died during the first year of life, one from severe pulmonary hypoplasia and one from apnea secondary to enterococcal pneumonia [<a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al 2008a</a>].</p><p><b>Muscle findings.</b> Muscle biopsy reveals variable findings:</p><ul><li class="half_rhythm"><div><b>Light microscopy.</b> Small type I and II fibers in some individuals and fiber-type disproportion in others. Increased numbers of central nuclei may be seen.</div></li><li class="half_rhythm"><div><b>Electron microscopy.</b> An increase in lipid droplets and/or subsarcolemmal mitochondrial accumulations</div></li></ul><p>Electromyogram revealed normal results in some individuals and evidence of myopathy in others [<a class="bk_pop" href="#stac3-dis.REF.stewart.1988.371">Stewart et al 1988</a>, <a class="bk_pop" href="#stac3-dis.REF.stamm.2008a.1832">Stamm et al 2008a</a>].</p></div><div id="stac3-dis.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>To date no <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are known.</p></div><div id="stac3-dis.Prevalence"><h3>Prevalence</h3><p><i>STAC3</i> disorder was originally identified in individuals of the Lumbee Native American tribe, which is recognized by the state of North Carolina and has approximately 60,000 enrolled members. The ancestry of Lumbee Native Americans is a mixture of Cheraw Indian, English, and African American [<a class="bk_pop" href="#stac3-dis.REF.stamm.2008b.1764">Stamm et al 2008b</a>]. A founder <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in this population (see <a href="#stac3-dis.Molecular_Genetics">Molecular Genetics</a>). It is estimated that one in 5,000 Lumbee Native Americans has <i>STAC3</i> disorder.</p><p>See <a href="#stac3-dis.Clinical_Description">Clinical Description</a> for other populations in which <i>STAC3</i> disorder has been observed.</p></div></div><div id="stac3-dis.Genetically_Related_Allelic_Di"><h2 id="_stac3-dis_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>STAC3</i>.</p></div><div id="stac3-dis.Differential_Diagnosis"><h2 id="_stac3-dis_Differential_Diagnosis_">Differential Diagnosis</h2><div id="stac3-dis.T.disorders_with_facial_weakne" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders with Facial Weakness and Hypotonia to Consider in the Differential Diagnosis of <i>STAC3</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.T.disorders_with_facial_weakne/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.T.disorders_with_facial_weakne_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Additional Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4" id="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>STAC3</i> Disorder</th><th headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4" id="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>STAC3</i> Disorder</th></tr></thead><tbody><tr><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Central core disease<br />(OMIM <a href="https://omim.org/entry/117000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">117000</a>)</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><i>RYR1</i></td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4 hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_2_1" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Respiratory insufficiency</div></li><li class="half_rhythm"><div>Contractures</div></li><li class="half_rhythm"><div>Arthrogryposis</div></li><li class="half_rhythm"><div>Susceptibility to MH</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4 hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_2_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>External ophthalmoplegia may be present.</div></li><li class="half_rhythm"><div>Serum CK may be &#x02191; in King-Denborough syndrome.</div></li></ul>
</td></tr><tr><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RYR1</i>-related <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> fiber-type disproportion</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RYR1</i>-related multiminicore disease</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RYR1</i>-related King-Denborough syndrome&#x000a0;<sup>1</sup><br />(see <a href="/books/n/gene/mhs/">Malignant Hyperthermia Susceptibility</a>)</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carey Fineman Ziter syndrome&#x000a0;<sup>2</sup><br />(OMIM <a href="https://omim.org/entry/254940" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">254940</a>)</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYMK</i></td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4 hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Upturned/broad nasal tip</div></li><li class="half_rhythm"><div>Micro/retrognathia</div></li><li class="half_rhythm"><div>Generalized muscle hypoplasia</div></li><li class="half_rhythm"><div>Delayed motor milestones</div></li><li class="half_rhythm"><div>Normal cognition</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4 hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No susceptibility to MH documented to date</td></tr><tr><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moebius syndrome&#x000a0;<sup>3</sup><br />(OMIM <a href="https://omim.org/entry/157900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">157900</a>)</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown etiology<br />in most<br />cases&#x000a0;<sup>4</sup><br /><i>PLXND1</i><br /><i>REV3L</i>&#x000a0;<sup>5</sup></td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown<br />in most<br />cases;<br />AD in<br />small # of<br />patients&#x000a0;<sup>4</sup></td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4 hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cleft palate</div></li><li class="half_rhythm"><div>Talipes equinovarus</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Joint contractures</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_1_4 hd_h_stac3-dis.T.disorders_with_facial_weakne_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Impairment in ocular abduction is obligatory.</div></li><li class="half_rhythm"><div>Variably present:</div><ul><li class="half_rhythm"><div>Cranial nerve abnormalities</div></li><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Poland anomaly</div></li><li class="half_rhythm"><div>Limb reduction defects</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>ASD</div></li></ul></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ASD = autism spectrum disorder; DD = developmental delay; MH = malignant hyperthermia; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="stac3-dis.TF.3.1"><p class="no_margin"><a class="bk_pop" href="#stac3-dis.REF.king.1973.37">King &#x00026; Denborough [1973]</a>, <a class="bk_pop" href="#stac3-dis.REF.darcy.2008.776">D'Arcy et al [2008]</a>, <a class="bk_pop" href="#stac3-dis.REF.dowling.2011.420">Dowling et al [2011]</a></p></div></dd><dt>2. </dt><dd><div id="stac3-dis.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#stac3-dis.REF.carey.1982.858">Carey et al [1982]</a>, <a class="bk_pop" href="#stac3-dis.REF.di_gioia.2017.16077">Di Gioia et al [2017]</a>, <a class="bk_pop" href="#stac3-dis.REF.telegrafi.2017.2763">Telegrafi et al [2017]</a>, <a class="bk_pop" href="#stac3-dis.REF.alrohaif.2018.e226">Alrohaif et al [2018]</a>, <a class="bk_pop" href="#stac3-dis.REF.hedbergoldfors.2018.e254">Hedberg-Oldfors et al [2018]</a></p></div></dd><dt>3. </dt><dd><div id="stac3-dis.TF.3.3"><p class="no_margin">Moebius syndrome was defined by the Moebius Syndrome Foundation Research Conference with the minimum criteria of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, nonprogressive facial weakness with limited abduction of one or both eyes [<a class="bk_pop" href="#stac3-dis.REF.miller.2007.826">Miller 2007</a>].</p></div></dd><dt>4. </dt><dd><div id="stac3-dis.TF.3.4"><p class="no_margin">Both genetic and environmental etiologies have been proposed. Additionally, prenatal exposure to misoprostol and other agents has been known to cause a Moebius syndrome <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div></dd><dt>5. </dt><dd><div id="stac3-dis.TF.3.5"><p class="no_margin">Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants in <i>PLXND1</i> and <i>REV3L</i> have been described in a small number of individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> facial weakness associated with a variety of additional findings that overlap the Moebius syndrome spectrum [<a class="bk_pop" href="#stac3-dis.REF.tomasroca.2015.7199">Tomas-Roca et al 2015</a>].</p></div></dd></dl></div></div></div></div><div id="stac3-dis.Management"><h2 id="_stac3-dis_Management_">Management</h2><div id="stac3-dis.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>STAC3</i> disorder, the evaluations summarized in <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.recommended_evaluations_foll/?report=objectonly" target="object" rid-figpopup="figstac3disTrecommendedevaluationsfoll" rid-ob="figobstac3disTrecommendedevaluationsfoll">Table 4</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="stac3-dis.T.recommended_evaluations_foll" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>STAC3</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.T.recommended_evaluations_foll/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.T.recommended_evaluations_foll_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">System/Concern</th><th id="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Evaluation</th><th id="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measure height, weight, head circumference.</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for evidence of failure to thrive.</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neuromuscular</b></td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to pediatric or adult neurologist.</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess severity of muscle weakness.</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Refer to neuromuscular clinic incl physical medicine &#x00026; rehabilitation / PT / OT evaluation.</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess need for PT &#x00026;/or OT &#x00026; adaptive equipment.</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthopedic / physical medicine &#x00026; rehabilitation / PT / OT evaluation in multidisciplinary neuromuscular clinic</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for kyphoscoliosis, talipes deformities, &#x00026; joint contractures.</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ptosis</b></td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to pediatric or adult ophthalmologist; may be part of craniofacial team.</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess extraocular movements, visual acuity, &#x00026; visual field.</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding issues</b></td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to speech therapist, OT, nutritionist, or multidisciplinary craniofacial team.</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluations may incl:
<ul><li class="half_rhythm"><div>Physical examination</div></li><li class="half_rhythm"><div>Clinical feeding evaluation using different types of nipples</div></li><li class="half_rhythm"><div>Video fluoroscopic swallow study</div></li><li class="half_rhythm"><div>Laboratory evaluation (e.g., total carbon dioxide level)</div></li><li class="half_rhythm"><div>Chest x-ray</div></li><li class="half_rhythm"><div>Upper gastrointestinal series</div></li></ul>
</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Palatal anomalies</b><br /><b>incl cleft palate</b></td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to multidisciplinary craniofacial team.</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Team will assess effect of palatal anomalies on feeding, speech development, &#x00026; need for surgical interventions.</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to pulmonologist</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Polysomnography needed to evaluate for central &#x00026;/or obstructive sleep apnea as well as hypoxia</div></li><li class="half_rhythm"><div>Spirometry plus measurement of maximal inspiratory &#x00026; expiratory pressures &#x00026; cough peak flow</div></li><li class="half_rhythm"><div>For older children &#x00026; adults, pulmonary function tests may be helpful.</div></li><li class="half_rhythm"><div>If concern for ascending or descending microaspiration, evaluate for chronic lung disease.</div></li><li class="half_rhythm"><div>Severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants should be evaluated for pulmonary hypoplasia.</div></li></ul>
</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Review natural history of disorder, <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>, <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>, &#x00026; prognosis.</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Obtain surgical history.</td><td headers="hd_h_stac3-dis.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for evidence of MH.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MH = malignant hyperthermia; OT = occupational therapy; PT = physical therapy</p></div></dd></dl></div></div></div></div><div id="stac3-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>At present, no treatment halts or reverses the manifestations of <i>STAC3</i> disorder; treatment involves reducing symptoms and preventing secondary complications (see <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.treatment_of_manifestations/?report=objectonly" target="object" rid-figpopup="figstac3disTtreatmentofmanifestations" rid-ob="figobstac3disTtreatmentofmanifestations">Table 5</a>).</p><div id="stac3-dis.T.treatment_of_manifestations" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>STAC3</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.T.treatment_of_manifestations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.T.treatment_of_manifestations_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypotonia/</b><br /><b>Myopathy</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OT &#x00026; PT</td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider use of adaptive devices to improve mobility.</td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Contractures</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider:
<ul><li class="half_rhythm"><div>PT to improve range of motion</div></li><li class="half_rhythm"><div>Stretching, night splints, or serial casts</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Avoid periods of prolonged immobilization (e.g., following surgery).</td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Talipes</b><br /><b>equinovarus</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As per recommendations of treating orthopedist</td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Serial casting, splinting, &#x00026; surgical intervention may be required.</td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As per recommendations of treating orthopedist</td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Often initial bracing is followed by progressive scoliosis requiring surgery.</td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ptosis</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical repair, such as levator resection or frontalis sling surgeries</td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Uncorrected ptosis may lead to &#x02193; visual acuity &#x00026; &#x02193; visual fields. Superior visual field loss is most common.</td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Poor weight gain /</b><br /><b>Weight-faltering</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of caloric intake; high-calorie foods/formulas &#x00026;/or supplementation via nasogastric or enteral feeding may be necessary.</td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Poor feeding</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As per recommendations of speech therapist/OT, nutritionist, or multidisciplinary craniofacial team</td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May incl specialized bottles, nasogastric or enteral feeding tube,&#x000a0;<sup>1</sup> feeding therapy</td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cleft palate</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Specialized cleft bottles; timing &#x00026; type of surgical repair determined by craniofacial team&#x000a0;<sup>1</sup></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If micrognathia also present, may be evaluated for Robin sequence</td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech issues</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment by speech-language pathologist as part of multidisciplinary craniofacial team&#x000a0;<sup>2</sup></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Interventions depend on etiology of speech issues, &#x00026; may include speech therapy, surgery, &#x00026;/or use of assistive communication devices.</td></tr><tr><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b><br /><b>insufficiency</b></td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Invasive or noninvasive ventilatory support, mechanical cough assist (in exsufflator)</div></li><li class="half_rhythm"><div>As per recommendations of pulmonary &#x00026; craniofacial team</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Aggressive treatment &#x00026; prevention of lower respiratory tract infections (influenza &#x00026; PCV-23 vaccines)</div></li><li class="half_rhythm"><div>May incl need for noninvasive or invasive positive pressure ventilation (e.g., CPAP, BiPAP via mask, tracheostomy w/ventilation); assessment for ascending or descending microaspiration w/appropriate interventions</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">OT = occupational therapy; PT = physical therapy</p></div></dd><dt>1. </dt><dd><div id="stac3-dis.TF.5.1"><p class="no_margin">Enteral feeding tubes may be needed if there is concern for aspiration or if the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is unable to take in adequate calories for growth. Some children with more significant respiratory issues may require surgical feeding tubes and/or procedures to protect their lungs from microaspiration.</p></div></dd><dt>2. </dt><dd><div id="stac3-dis.TF.5.2"><p class="no_margin">Due to the complexity of speech evaluation in children with myopathic facies, structural differences with or without cleft palate, a speech-language pathologist on a multidisciplinary craniofacial team will be needed to determine the contributing factors in most children.</p></div></dd></dl></div></div></div></div><div id="stac3-dis.Surveillance"><h3>Surveillance</h3><div id="stac3-dis.T.recommended_surveillance_for" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>STAC3</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.T.recommended_surveillance_for/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.T.recommended_surveillance_for_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Recommended Frequency</th></tr></thead><tbody><tr><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PCP should monitor growth incl weight, height, &#x00026; head circumference.</td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every visit</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neuromuscular</b></td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multidisciplinary neuromuscular clinic monitor:
<ul><li class="half_rhythm"><div>Respiratory status, speech development, swallowing function</div></li><li class="half_rhythm"><div>Musculoskeletal complications (e.g., scoliosis &#x00026;/or joint contractures)</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Infants age &#x0003c;12 months: every 3-4 mos</div></li><li class="half_rhythm"><div>Older children &#x00026; adults: every 6-12 mos</div></li></ul>
</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cleft palate</b></td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multidisciplinary craniofacial team:
<ul><li class="half_rhythm"><div>Equipment &#x00026; techniques for feeding infants w/cleft palate</div></li><li class="half_rhythm"><div>Surgical repair timing &#x00026; type of procedure determined by team</div></li><li class="half_rhythm"><div>Anesthesiologist should be aware of risk of MH.</div></li><li class="half_rhythm"><div>Audiologic evaluation as part of craniofacial team as needed</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Infants: visit frequency determined by feeding &#x00026; respiratory issues</div></li><li class="half_rhythm"><div>Children: varies depending on comorbidities; at least annually</div></li></ul>
</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding</b></td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multidisciplinary craniofacial team in conjunction w/PCP: measurement of growth parameters</td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Evaluation of nutritional status &#x00026; safety of oral intake</div></li><li class="half_rhythm"><div>Consider clinical feeding evaluation &#x00026;/or video fluoroscopic swallow study.</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pulmonologist:
<ul><li class="half_rhythm"><div>Assessment of pulmonary status &#x00026; pulmonary function testing</div></li><li class="half_rhythm"><div>Polysomnography</div></li><li class="half_rhythm"><div>Evaluate for signs of ascending or descending aspiration.</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical evaluation at least annually but likely more often during infancy or when any signs of respiratory insufficiency, aspiration, &#x00026;/or sleep apnea develop</td></tr><tr><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech</b></td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multidisciplinary craniofacial team:
<ul><li class="half_rhythm"><div>Speech assessment by speech-language pathologist familiar w/cleft palate &#x00026; neuromuscular contributors to speech issues</div></li><li class="half_rhythm"><div>Consider speech therapy, surgical interventions, &#x00026; augmentative communication devices</div></li></ul>
</td><td headers="hd_h_stac3-dis.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least annually</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#stac3-dis.REF.wang.2012.363">Wang et al [2012]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">MH = malignant hyperthermia; PCP = primary care physician</p></div></dd></dl></div></div></div></div><div id="stac3-dis.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Persons with <i>STAC3</i> disorder are at increased risk for malignant hyperthermia (MH) crises when exposed to certain agents used with general anesthesia &#x02013; most commonly volatile anesthetic gases (including halothane, isoflurane, and sevoflurane) and depolarizing muscle relaxants (e.g., succinylcholine and decamethonium). It is imperative that persons with <i>STAC3</i> disorder discuss their diagnosis with anesthesiologists and treating physicians prior to surgical procedures to ensure that appropriate anesthetics are chosen to reduce the risk of MH.</p></div><div id="stac3-dis.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#stac3-dis.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="stac3-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="stac3-dis.Genetic_Counseling"><h2 id="_stac3-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="stac3-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>STAC3</i> disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>STAC3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with <i>STAC3</i> disorder has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>STAC3.</i></p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>STAC3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="stac3-dis.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>STAC3</i> pathogenic variants in the family.</p></div><div id="stac3-dis.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="stac3-dis.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>STAC3</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="stac3-dis.Resources"><h2 id="_stac3-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Malignant Hyperthermia Association of the United States (MHAUS)</b></div><div>11 East State Street</div><div>PO Box 1069</div><div>Sherburne NY 13460</div><div><b>Phone:</b> 800-644-9737 (Toll-free Emergency Hotline); 607-674-7901; 315-464-7079</div><div><b>Fax:</b> 607-674-7910</div><div><b>Email:</b> info@mhaus.org</div><div><a href="http://www.mhaus.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mhaus.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li></ul></div><div id="stac3-dis.Molecular_Genetics"><h2 id="_stac3-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="stac3-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>STAC3 Disorder: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_stac3-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_stac3-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_stac3-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_stac3-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_stac3-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_stac3-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/246329" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>STAC3</i></a></td><td headers="hd_b_stac3-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=246329" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_stac3-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96MF2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SH3 and cysteine-rich domain-containing protein 3</a></td><td headers="hd_b_stac3-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=STAC3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">STAC3</a></td><td headers="hd_b_stac3-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=STAC3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">STAC3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="stac3-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="stac3-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for STAC3 Disorder (<a href="/omim/255995,615521" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/255995" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">255995</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615521" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615521</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SH3 AND CYSTEINE-RICH DOMAINS 3; STAC3</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>STAC3</i> spans more than 7 kb and encodes for at least three alternatively spliced transcripts. The longest transcript variant (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_145064.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_145064.2</a>) has 12 exons and is composed of 1,668 base pairs.</p><p>See <a href="/books/NBK542808/#stac3-dis.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcripts, and protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>.</p><p><b>Pathogenic variants.</b> Molecularly confirmed <i>STAC3</i> disorder has been reported for 28 individuals from 20 families. To date, a total of five pathogenic variants have been identified.</p><p><a class="bk_pop" href="#stac3-dis.REF.horstick.2013.1952">Horstick et al [2013]</a> identified <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.stac3_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figstac3disTstac3pathogenicvariantsdi" rid-ob="figobstac3disTstac3pathogenicvariantsdi">c.851G&#x0003e;C</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in five <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from five Lumbee Native American families.</p><p><a class="bk_pop" href="#stac3-dis.REF.grzybowski.2017.451">Grzybowski et al [2017]</a> identified <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic <i>STAC3</i> variants in one individual of Turkish ancestry that included a <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> change (<a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.stac3_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figstac3disTstac3pathogenicvariantsdi" rid-ob="figobstac3disTstac3pathogenicvariantsdi">c.862A&#x0003e;T</a>) and a splice donor site variant <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.stac3_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figstac3disTstac3pathogenicvariantsdi" rid-ob="figobstac3disTstac3pathogenicvariantsdi">c.432+4A&#x0003e;T</a>.</p><p><a class="bk_pop" href="#stac3-dis.REF.telegrafi.2017.2763">Telegrafi et al [2017]</a> reported two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sisters of Qatari ancestry who were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the c.851G&#x0003e;C <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Two affected sibs of Puerto Rican ancestry were <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for the c.851G&#x0003e;C and <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.stac3_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figstac3disTstac3pathogenicvariantsdi" rid-ob="figobstac3disTstac3pathogenicvariantsdi">c.763_766delCTCT</a>
<i>STAC3</i> variants.</p><p><a class="bk_pop" href="#stac3-dis.REF.zaharieva.2018.1980">Zaharieva et al [2018]</a> reported 18 additional individuals from 12 families; of these, 17 from 11 families were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the c.851G&#x0003e;C <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (5 families of African descent, 3 of Middle Eastern descent, 1 of Afro-Caribbean descent, 1 of Comoro Islands descent, and 1 of South American descent). An additional individual of mixed African and Afro-Caribbean descent was a compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> for the variants c.851G&#x0003e;C and <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.stac3_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figstac3disTstac3pathogenicvariantsdi" rid-ob="figobstac3disTstac3pathogenicvariantsdi">c.997-1G&#x0003e;T</a>.</p><div id="stac3-dis.T.stac3_pathogenic_variants_di" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p><i>STAC3</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK542808/table/stac3-dis.T.stac3_pathogenic_variants_di/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__stac3-dis.T.stac3_pathogenic_variants_di_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.851G&#x0003e;C</td><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp284Ser</td><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_145064.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_145064<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_659501.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_659501<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.862A&#x0003e;T</td><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys288Ter</td></tr><tr><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.432+4A&#x0003e;T</td><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.763_766delCTCT</td><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu255Ilefster58</td></tr><tr><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.997-1G&#x0003e;T</td><td headers="hd_h_stac3-dis.T.stac3_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>STAC3</i> encodes SH3 and cysteine-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing protein 3 (STAC3), which is composed of 364 amino acids (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_659501.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_659501.1</a>) and has a calculated molecular mass of approximately 41.41 kd.</p><p>STAC3 contains an N-terminal cysteine-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and two SH3 domains.</p><p>STAC3 is a component of the excitation-contraction coupling machinery of muscles and biochemically associates with dihydropyridine receptor (DHPR) and ryanodine receptor 1 (RYR1) at triadic complexes, which are required for normal calcium release from the sarcoplasmic reticulum in skeletal muscle that leads to muscle contraction.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>STAC3</i> disorder results from <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants.</p><ul><li class="half_rhythm"><div>The c.851G&#x0003e;C <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant identified in Lumbee Native American families leads to decreases in the quantity, organization, stability, and voltage sensitivity of Ca<sup>2+</sup> channels [<a class="bk_pop" href="#stac3-dis.REF.horstick.2013.1952">Horstick et al 2013</a>].</div></li><li class="half_rhythm"><div><a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> studies confirmed two aberrant transcription products for the <a class="figpopup" href="/books/NBK542808/table/stac3-dis.T.stac3_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figstac3disTstac3pathogenicvariantsdi" rid-ob="figobstac3disTstac3pathogenicvariantsdi">c.432+4A&#x0003e;T</a> <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variant in lymphocytes, including skipping of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 and activation of a new <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 4 [<a class="bk_pop" href="#stac3-dis.REF.grzybowski.2017.451">Grzybowski et al 2017</a>].</div></li><li class="half_rhythm"><div>For the c.997-1G&#x0003e;T variant, <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> studies confirmed activation of a cryptic acceptor site within <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 12 leading to <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 12 nucleotides from mature <i>STAC3</i> RNA [<a class="bk_pop" href="#stac3-dis.REF.zaharieva.2018.1980">Zaharieva et al 2018</a>].</div></li></ul></div><div id="stac3-dis.References"><h2 id="_stac3-dis_References_">References</h2><div id="stac3-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.alrohaif.2018.e226">Alrohaif H, T&#x000f6;pf A, Evangelista T, Lek M, McArthur D, Lochm&#x000fc;ller H. Whole-exome sequencing identifies mutations in MYMK in a mild form of Carey-Fineman-Ziter syndrome. <span><span class="ref-journal">Neurol Genet. </span>2018;<span class="ref-vol">4</span>:e226.</span> [<a href="/pmc/articles/PMC5858950/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5858950</span></a>] [<a href="/pubmed/29560417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29560417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.bailey.1987.1043">Bailey AG, Bloch EC. Malignant hyperthermia in a three-month-old American Indian infant. <span><span class="ref-journal">Anesth Analg. </span>1987;<span class="ref-vol">66</span>:1043–5.</span> [<a href="/pubmed/3631569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3631569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.carey.1982.858">Carey JC, Fineman RM, Ziter FA. The Robin sequence as a consequence of malformation, dysplasia, and neuromuscular syndromes. <span><span class="ref-journal">J Pediatr. </span>1982;<span class="ref-vol">101</span>:858–64.</span> [<a href="/pubmed/7131178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7131178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.darcy.2008.776">D'Arcy CE, Bjorksten A, Yiu EM, Bankier A, Gillies R, McLean CA, Shield LK, Ryan MM. King-Denborough syndrome caused by a novel mutation in the ryanodine receptor gene. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:776–7.</span> [<a href="/pubmed/18765655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18765655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.di_gioia.2017.16077">Di Gioia SA, Connors S, Matsunami N, Cannavino J, Rose MF, Gilette NM, Artoni P, de Macena Sobreira NL, Chan WM, Webb BD, Robson CD, Cheng L, Van Ryzin C, Ramirez-Martinez A, Mohassel P, Leppert M, Scholand MB, Grunseich C, Ferreira CR, Hartman T, Hayes IM, Morgan T, Markie DM, Fagiolini M, Swift A, Chines PS, Speck-Martins CE, Collins FS, Jabs EW, B&#x000f6;nnemann CG, Olson EN, Carey JC, Robertson SP, Manoli I, Engle EC, et al.  A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome. <span><span class="ref-journal">Nat Commun. </span>2017;<span class="ref-vol">8</span>:16077.</span> [<a href="/pmc/articles/PMC5504296/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5504296</span></a>] [<a href="/pubmed/28681861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28681861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.dowling.2011.420">Dowling JJ, Lillis S, Amburgey K, Zhou H, Al-Sarraj S, Buk SJ, Wraige E, Chow G, Abbs S, Leber S, Lachlan K, Baralle D, Taylor A, Sewry C, Muntoni F, Jungbluth H. King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. <span><span class="ref-journal">Neuromuscul Disord. </span>2011;<span class="ref-vol">21</span>:420–7.</span> [<a href="/pubmed/21514828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21514828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.grzybowski.2017.451">Grzybowski M, Sch&#x000e4;nzer A, Pepler A, Heller C, Neubauer BA, Hahn A. Novel STAC3 mutations in the first non-Amerindian patient with Native American myopathy. <span><span class="ref-journal">Neuropediatrics. </span>2017;<span class="ref-vol">48</span>:451–5.</span> [<a href="/pubmed/28411587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28411587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.hall.2010">Hall J. Athrogryposis. In: Cassidy SB, Allanson, JE, eds. <em>Management of Genetic Syndromes</em>. 3rd ed. Hoboken, NJ: Wiley; 2010: 81-96.</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.hedbergoldfors.2018.e254">Hedberg-Oldfors C, Lindberg C, Oldfors A. Carey-Fineman-Ziter syndrome with mutations in the myomaker gene and muscle fiber hypertrophy. <span><span class="ref-journal">Neurol Genet. </span>2018;<span class="ref-vol">4</span>:e254.</span> [<a href="/pmc/articles/PMC6066360/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6066360</span></a>] [<a href="/pubmed/30065953" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30065953</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.horstick.2013.1952">Horstick EJ, Linsley JW, Dowling JJ, Hauser MA, McDonald KK, Ashley-Koch A, Saint-Amant L, Satish A, Cui WW, Zhou W, Sprague SM, Stamm DS, Powell CM, Speer MC, Franzini-Armstrong C, Hirata H, Kuwada JY. Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy. <span><span class="ref-journal">Nat Commun. </span>2013;<span class="ref-vol">4</span>:1952.</span> [<a href="/pmc/articles/PMC4056023/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4056023</span></a>] [<a href="/pubmed/23736855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23736855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.king.1973.37">King JO, Denborough MA. Anesthetic-induced malignant hyperpyrexia in children. <span><span class="ref-journal">J Pediatr. </span>1973;<span class="ref-vol">83</span>:37–40.</span> [<a href="/pubmed/4149045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4149045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.miller.2007.826">Miller G. Neurological disorders. The mystery of the missing smile. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">316</span>:826–7.</span> [<a href="/pubmed/17495152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17495152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.stamm.2008a.1832">Stamm DS, Aylsworth AS, Stajich JM, Kahler SG, Thorne LB, Speer MC, Powell CM. Native American myopathy: congenital myopathy with cleft palate, skeletal anomalies, and susceptibility to malignant hyperthermia. <span><span class="ref-journal">Am J Med Genet A. </span>2008a;<span class="ref-vol">146A</span>:1832–41.</span> [<a href="/pubmed/18553514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18553514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.stamm.2008b.1764">Stamm DS, Powell CM, Stajich JM, Zismann VL, Stephan DA, Chesnut B, Aylsworth AS, Kahler SG, Deak KL, Gilbert JR, Speer MC. Novel congenital myopathy locus identified in Native American Indians at 12q13.13-14.1. <span><span class="ref-journal">Neurology. </span>2008b;<span class="ref-vol">71</span>:1764–9.</span> [<a href="/pubmed/18843099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18843099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.stewart.1988.371">Stewart CR, Kahler SG, Gilchrist JM. Congenital myopathy with cleft palate and increased susceptibility to malignant hyperthermia: King syndrome? <span><span class="ref-journal">Pediatr Neurol. </span>1988;<span class="ref-vol">4</span>:371–4.</span> [<a href="/pubmed/3245876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3245876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.telegrafi.2017.2763">Telegrafi A, Webb BD, Robbins SM, Speck-Martins CE, FitzPatrick D, Fleming L, Redett R, Dufke A, Houge G, van Harssel JJT, Verloes A, Robles A, Manoli I, Engle EC, Jabs EW, Valle D, Carey J, Hoover-Fong JE, Sobreira NLM, et al.  Identification of STAC3 variants in non-Native American families with overlapping features of Carey-Fineman-Ziter syndrome and Moebius syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:2763–71.</span> [<a href="/pmc/articles/PMC5843189/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5843189</span></a>] [<a href="/pubmed/28777491" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28777491</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.tomasroca.2015.7199">Tomas-Roca L, Tsaalbi-Shtylik A, Jansen JG, Singh MK, Epstein JA, Altunoglu U, Verzijl H, Soria L, van Beusekom E, Roscioli T, Iqbal Z, Gilissen C, Hoischen A, de Brouwer AP, Erasmus C, Schubert D, Brunner H, P&#x000e9;rez Ayt&#x000e9;s A, Marin F, Aroca P, Kayserili H, Carta A, de Wind N, Padberg GW, van Bokhoven H. De novo mutations in PLXND1 and REV3L cause M&#x000f6;bius syndrome. <span><span class="ref-journal">Nat Commun. </span>2015;<span class="ref-vol">6</span>:7199.</span> [<a href="/pmc/articles/PMC4648025/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4648025</span></a>] [<a href="/pubmed/26068067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26068067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.wang.2012.363">Wang CH, Dowling JJ, North K, Schroth MK, Sejersen T, Shapiro F, Bellini J, Weiss H, Guillet M, Amburgey K, Apkon S, Bertini E, Bonnemann C, Clarke N, Connolly AM, Estournet-Mathiaud B, Fitzgerald D, Florence JM, Gee R, Gurgel-Giannetti J, Glanzman AM, Hofmeister B, Jungbluth H, Koumbourlis AC, Laing NG, Main M, Morrison LA, Munns C, Rose K, Schuler PM, Sewry C, Storhaug K, Vainzof M, Yuan N. Consensus statement on standard of care for congenital myopathies. <span><span class="ref-journal">J Child Neurol. </span>2012;<span class="ref-vol">27</span>:363–82.</span> [<a href="/pmc/articles/PMC5234865/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5234865</span></a>] [<a href="/pubmed/22431881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22431881</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="stac3-dis.REF.zaharieva.2018.1980">Zaharieva IT, Sarkozy A, Munot P, Manzur A, O'Grady G, Rendu J, Malfatti E, Amthor H, Servais L, Urtizberea JA, Neto OA, Zanoteli E, Donkervoort S, Taylor J, Dixon J, Poke G, Foley AR, Holmes C, Williams G, Holder M, Yum S, Medne L, Quijano-Roy S, Romero NB, Faur&#x000e9; J, Feng L, Bastaki L, Davis MR, Phadke R, Sewry CA, B&#x000f6;nnemann CG, Jungbluth H, Bachmann C, Treves S, Muntoni F. STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility. <span><span class="ref-journal">Hum Mutat. </span>2018;<span class="ref-vol">39</span>:1980–94.</span> [<a href="/pubmed/30168660" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30168660</span></a>]</div></li></ul></div></div><div id="stac3-dis.Chapter_Notes"><h2 id="_stac3-dis_Chapter_Notes_">Chapter Notes</h2><div id="stac3-dis.Author_Notes"><h3>Author Notes</h3><p>Bryn Webb is a clinical geneticist, clinical molecular geneticist, and pediatrician specializing in genetic studies of rare <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies. She is co-director of the Cleft and Craniofacial Program at the Icahn School of Medicine at Mount Sinai. <a href="http://labs.icahn.mssm.edu/webblab/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Webb Laboratory</a></p><p>Irini Manoli is a clinical and biochemical geneticist and pediatrician with a focus on clinical and translational research in rare genetic syndromes and inborn errors of metabolism. She works at the National Human Genome Research Institute of the National Institutes of Health.</p><p>Ethylin Wang Jabs is a medical geneticist with a clinical focus in dysmorphology and a clinical, translational, and basic research interest in developmental genetics, in particular craniofacial disorders. <a href="http://icahn.mssm.edu/research/labs/ethylin-wang-jabs-laboratory" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ethylin Wang Jabs Laboratory</a></p></div><div id="stac3-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>20 June 2019 (bp) Review posted live</div></li><li class="half_rhythm"><div>13 August 2018 (bw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK542808</span><span class="label">PMID: <a href="/pubmed/31219695" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31219695</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hsn1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/stxbp1-ee/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK542808&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK542808/?report=reader">PubReader</a></li><li><a href="/books/NBK542808/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK542808" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK542808" style="display:none" title="Cite this Page"><div class="bk_tt">Webb BD, Manoli I, Jabs EW. STAC3 Disorder. 2019 Jun 20. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK542808/pdf/Bookshelf_NBK542808.pdf">PDF version of this page</a> (486K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#stac3-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#stac3-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#stac3-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#stac3-dis.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#stac3-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#stac3-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#stac3-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#stac3-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#stac3-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#stac3-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#stac3-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=246329[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">STAC3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4788570" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4788570" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4788570" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4788570" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28777491" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Identification of STAC3 variants in non-Native American families with overlapping features of Carey-Fineman-Ziter syndrome and Moebius syndrome.</a><span class="source">[Am J Med Genet A. 2017]</span><div class="brieflinkpop offscreen_noflow">Identification of STAC3 variants in non-Native American families with overlapping features of Carey-Fineman-Ziter syndrome and Moebius syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Telegrafi A, Webb BD, Robbins SM, Speck-Martins CE, FitzPatrick D, Fleming L, Redett R, Dufke A, Houge G, van Harssel JJT, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2017 Oct; 173(10):2763-2771. Epub 2017 Aug 4.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301468" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sparks SE, Quijano-Roy S, Harper A, Rutkowski A, Gordon E, Hoffman EP, Pegoraro E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301565" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malicdan MCV, Nishino I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30869852" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> FARS2 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> FARS2 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Almannai M, Faqeih E, El-Hattab AW, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301347" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Myasthenic Syndromes</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Myasthenic Syndromes<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Abicht A, Müller J S, Lochmüller H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31219695" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31219695" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041768dde089116925957a">STAC3 Disorder - GeneReviews®</a><div class="ralinkpop offscreen_noflow">STAC3 Disorder - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:14:00-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BD8C0E0417101000000000029000C&amp;ncbi_session=CE8BD8C0E0417671_0041SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK542808%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK542808&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK542808/&amp;ncbi_pagename=STAC3 Disorder - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BD8C0E0417671_0041SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>